Theratechnologies' Annual Meeting of Shareholders Overview
On a recent date, Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) conducted its annual meeting of shareholders, engaging participants in a fully virtual format. This approach aims to foster broader participation while ensuring safety and convenience for all involved.
Electing New Board Members
During the meeting, shareholders cast their votes, successfully electing well-qualified individuals to the Company’s Board of Directors. This election process highlights the active involvement of shareholders in guiding the company’s strategic direction. Those elected will serve for a one-year term, bringing their diverse expertise to the table, which is essential for steering Theratechnologies toward continued growth and innovation.
Voting Results Breakdown
All proposed candidates received a significant majority of support from the shareholders. The voting results for the board elections showcased a healthy democratic process:
- **Joseph Arena**: 20,473,944 votes (84.03% in favor)
- **Frank Holler**: 19,089,786 votes (78.35% in favor)
- **Paul Lévesque**: 19,027,772 votes (78.10% in favor)
- **Andrew Molson**: 19,066,145 votes (78.25% in favor)
- **Dawn Svoronos**: 18,998,230 votes (77.98% in favor)
- **Elina Tea**: 19,163,502 votes (78.65% in favor)
- **Dale Weil**: 19,005,768 votes (78.01% in favor)
- **Jordan Zwick**: 19,618,725 votes (80.52% in favor)
Company’s Focus on Governance and Transparency
In addition to electing board members, shareholders appointed KPMG LLP as the auditors for the current fiscal year. This decision reflects the Company's commitment to maintaining high standards of financial integrity and transparency. Senior management emphasized that improving governance is a key priority, strengthening confidence among investors.
Long-Term Incentive Plans
Furthermore, the meeting saw the approval of an omnibus long-term incentive plan, aimed at providing benefits not only to board members but also to executive officers and employees. Such incentives are crucial in aligning the interests of all stakeholders with the company’s long-term success and fostering a culture of high performance and innovation.
About Theratechnologies
Theratechnologies specializes in developing and commercializing groundbreaking therapies that have the potential to enhance treatment standards in health care. By prioritizing innovative solutions, the company aims to improve patient outcomes significantly across various therapeutic areas. More information about the company’s offerings and strategic plans is accessible from the Company's official website at www.theratech.com and through financial reporting platforms such as SEDAR+ and EDGAR.
Investor Relations Contact
For investor inquiries, stakeholders are encouraged to reach out to:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
Phone: 438-315-6608
Media Relations Contact
For media inquiries, the following contact is available:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
Phone: 514-336-7800
Frequently Asked Questions
What is the purpose of Theratechnologies' annual meeting?
The annual meeting allows shareholders to vote on crucial company matters, including board elections and financial audits.
Who were elected to the Board of Directors?
Several candidates including Joseph Arena and Frank Holler were elected, showcasing strong support from shareholders.
Why was KPMG LLP chosen as auditors?
KPMG LLP's appointment reflects Theratechnologies' commitment to transparency and financial integrity.
What is the long-term incentive plan?
The omnibus long-term incentive plan is designed to reward directors, officers, and employees and align their interests with the company's growth.
How can I learn more about Theratechnologies?
More details are available on Theratechnologies' website and through financial reporting services like SEDAR+ and EDGAR.
